BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 15721415)

  • 21. Changes in the topological expression of markers of differentiation and apoptosis in defined stages of human cervical dysplasia and carcinoma.
    Zanotti S; Fisseler-Eckhoff A; Mannherz HG
    Gynecol Oncol; 2003 Jun; 89(3):376-84. PubMed ID: 12798698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis.
    Maduro JH; de Vries EG; Meersma GJ; Hougardy BM; van der Zee AG; de Jong S
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):543-52. PubMed ID: 18793956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TRAIL/Apo-2 ligand induces primary plasma cell apoptosis.
    Ursini-Siegel J; Zhang W; Altmeyer A; Hatada EN; Do RK; Yagita H; Chen-Kiang S
    J Immunol; 2002 Nov; 169(10):5505-13. PubMed ID: 12421926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical detection of metallothionein and MIB1 in uterine cervical squamous lesions.
    McCluggage WG; Maxwell P; Bharucha H
    Int J Gynecol Pathol; 1998 Jan; 17(1):29-35. PubMed ID: 9475189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The bile acid glycochenodeoxycholate induces trail-receptor 2/DR5 expression and apoptosis.
    Higuchi H; Bronk SF; Takikawa Y; Werneburg N; Takimoto R; El-Deiry W; Gores GJ
    J Biol Chem; 2001 Oct; 276(42):38610-8. PubMed ID: 11507096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient TRAIL-R1/DR4-mediated apoptosis in melanoma cells by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Kurbanov BM; Geilen CC; Fecker LF; Orfanos CE; Eberle J
    J Invest Dermatol; 2005 Nov; 125(5):1010-9. PubMed ID: 16297203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling.
    Kelley RF; Totpal K; Lindstrom SH; Mathieu M; Billeci K; Deforge L; Pai R; Hymowitz SG; Ashkenazi A
    J Biol Chem; 2005 Jan; 280(3):2205-12. PubMed ID: 15520016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha.
    Sheikh MS; Burns TF; Huang Y; Wu GS; Amundson S; Brooks KS; Fornace AJ; el-Deiry WS
    Cancer Res; 1998 Apr; 58(8):1593-8. PubMed ID: 9563466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of tumour necrosis factor-related apoptosis-inducing ligand death receptors in sporadic and hereditary colorectal tumours: potential targets for apoptosis induction.
    Koornstra JJ; Jalving M; Rijcken FE; Westra J; Zwart N; Hollema H; de Vries EG; Hofstra RW; Plukker JT; de Jong S; Kleibeuker JH
    Eur J Cancer; 2005 May; 41(8):1195-202. PubMed ID: 15911244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reovirus-induced apoptosis is mediated by TRAIL.
    Clarke P; Meintzer SM; Gibson S; Widmann C; Garrington TP; Johnson GL; Tyler KL
    J Virol; 2000 Sep; 74(17):8135-9. PubMed ID: 10933724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The C-terminal tails of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas receptors have opposing functions in Fas-associated death domain (FADD) recruitment and can regulate agonist-specific mechanisms of receptor activation.
    Thomas LR; Johnson RL; Reed JC; Thorburn A
    J Biol Chem; 2004 Dec; 279(50):52479-86. PubMed ID: 15452120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell surface Death Receptor signaling in normal and cancer cells.
    Ozören N; El-Deiry WS
    Semin Cancer Biol; 2003 Apr; 13(2):135-47. PubMed ID: 12654257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing.
    Poulaki V; Mitsiades CS; McMullan C; Fanourakis G; Negri J; Goudopoulou A; Halikias IX; Voutsinas G; Tseleni-Balafouta S; Miller JW; Mitsiades N
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):358-66. PubMed ID: 15623796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of TRAIL (TNF-related apoptosis-inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomas.
    Koornstra JJ; Kleibeuker JH; van Geelen CM; Rijcken FE; Hollema H; de Vries EG; de Jong S
    J Pathol; 2003 Jul; 200(3):327-35. PubMed ID: 12845629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perturbation of the tumor necrosis factor--related apoptosis-inducing ligand cascade in ovarian cancer: overexpression of FLIPL and deregulation of the functional receptors DR4 and DR5.
    Horak P; Pils D; Kaider A; Pinter A; Elandt K; Sax C; Zielinski CC; Horvat R; Zeillinger R; Reinthaller A; Krainer M
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8585-91. PubMed ID: 16361541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic peptides corresponding to ligand-binding region of death receptors, DR5, Fas, and TNFR, specifically inhibit cell death mediated by the death ligands, respectively.
    Kajiwara K; Saito A; Ogata S; Tanihara M
    Biochim Biophys Acta; 2004 Jun; 1699(1-2):131-7. PubMed ID: 15158720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The expression of TRAIL, TRAIL-R (DR4, DcR1) and Fas-L in patients with ovarian cancer].
    Li CM; Peng ZL; Yang KX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):341-3. PubMed ID: 15931863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of phosphorylated histone H2AX (γ-H2AX) in normal and neoplastic squamous epithelia of the uterine cervix: an immunohistochemical study with epidermal growth factor receptor.
    Brustmann H; Hinterholzer S; Brunner A
    Int J Gynecol Pathol; 2011 Jan; 30(1):76-83. PubMed ID: 21131828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. nm23-H1 protein immunoreactivity in intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix.
    Lee CS; Gad J
    Pathol Int; 1998 Oct; 48(10):806-11. PubMed ID: 9788265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes of cell adhesion and extracellular matrix (ECM) components in cervical intraepithelial neoplasia.
    Sobel G; Szabó I; Páska C; Kiss A; Kovalszky I; Kádár A; Paulin F; Schaff Z
    Pathol Oncol Res; 2005; 11(1):26-31. PubMed ID: 15800679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.